David Calvet Canut on Europe’s Plasma Dependency
David Calvet Canut, Director TFE at UNIR, shared on LinkedIn:
”Europe’s reliance on imported plasma is a critical issue that demands immediate attention.
The use of plasma in producing vital medical components underscores its importance in healthcare.
However, Europe’s heavy dependence on U.S. imports jeopardizes patient care and the stability of the medical supply chain.
This situation also raises ethical concerns, as purely profit-driven approaches may compromise patient safety and well-being.
Addressing this challenge requires a comprehensive strategy that integrates legal, ethical, and scientific considerations.
By enhancing local plasma sourcing and adopting robust governance measures, Europe can strengthen its healthcare resilience and ensure a sustainable supply of essential therapeutics.
Emphasizing donor safety, ethical standards in medicine, and strong governance practices is paramount to safeguarding the region’s health infrastructure.
Misaligned countries’ policies and standards could represent a risk for companies crossing the red lines of legal and ethic frameworks even without being fully aware of such behavior.”
Read the full article here.
Stay updated with Hemostasis Today.
-
Nov 15, 2025, 12:24Thomas Reiser: Can AI Keep Up with Thrombosis Specialists?
-
Nov 15, 2025, 12:13Michael Makris on Immediate Suspension of Use of Plasma Derived FIX Concentrates in Punjab
-
Nov 15, 2025, 09:32Tushar Pandey: Hounoured to Be Part of Hematocon 2025
-
Nov 15, 2025, 09:11Lisa Murphy invites You to Join Her at Stroke Foundation’s Run4Stroke Marathon
-
Nov 15, 2025, 08:56Ahmed Bennis on Potential Use of P2Y12 Inhibitors as Safer Alternative in Monotherapy
-
Nov 15, 2025, 08:39Marika Nöjd: Donating Blood is An Easy Way to Do Good!
-
Nov 15, 2025, 08:19Joseph Caprini Released His UIP 2025 Session on VTE Recurrence Risk
-
Nov 15, 2025, 07:14Paul Bolaji Invites You to ”Thrombolytic Therapy in Acute Stroke in African Patients” Seminar
-
Nov 15, 2025, 07:03Carla Goulart Peron Explores The Role of Technology and Collaboration in Global Stroke Action